<DOC>
	<DOC>NCT00421655</DOC>
	<brief_summary>The trial is performed to evaluate the efficacy and safety of specific immunotherapy with Grazax for treatment of grass pollen induced allergy.</brief_summary>
	<brief_title>A Trial of Grazax in Subjects With Hayfever</brief_title>
	<detailed_description />
	<criteria>History of grass pollen allergy Positive skin prick test to grass Positive specific IgE to grass Exclusion Criteria FEV1 &lt;70% of predicted value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>